Overview of HGH Fragment 176-191 Research Properties
HGH Fragment 176-191 is a synthetic peptide derived from the C-terminal portion of human growth hormone, specifically encompassing amino acids 176-191. This fragment represents approximately 10% of the complete growth hormone molecule and has been extensively investigated in metabolic research applications. The peptide maintains the structural characteristics associated with the lipolytic domain of growth hormone while eliminating other biological activities of the parent hormone. Researchers at Stroid UK Shop frequently study this compound for its selective metabolic properties in controlled laboratory environments.
Laboratory Research Applications
In preclinical studies, HGH Fragment 176-191 has demonstrated selective activity on adipose tissue metabolism without affecting glucose homeostasis or insulin sensitivity markers that are typically associated with full-length growth hormone. The peptide sequence retains specific receptor binding characteristics that make it valuable for investigating lipolytic pathways and fat metabolism mechanisms. Research protocols commonly examine its effects on cellular energy utilisation and adipocyte function in various experimental models. Scientists working with fragment peptides often compare this compound to other metabolic modulators and SARMs to understand different regulatory pathways. Additionally, researchers studying peptides utilise this fragment to investigate the structure-activity relationships within the growth hormone family.
Technical Specifications
| Parameter | Specification |
|---|---|
| Amino Acid Sequence | 16 amino acids (positions 176-191 of hGH) |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Approximately 1.8 kDa |
| Purity | Pharmaceutical grade |
| Appearance | White lyophilised powder |
| Storage Requirements | -20°C for long-term storage |
| Reconstitution | Bacteriostatic water or sterile saline |
| Stability | 2-8°C post-reconstitution, use within 30 days |
Research Compliance Information
This HGH Fragment 176-191 peptide is manufactured to pharmaceutical standards for in-vitro research applications only. All studies must be conducted within appropriate laboratory settings by qualified researchers following institutional protocols. This compound is not intended for human consumption, therapeutic use, or any application outside of controlled scientific research. Researchers must ensure compliance with local regulations regarding peptide research and maintain proper documentation of all experimental procedures.
